# Efficacy and Safety of Ciprofol in Laparoscopic Sleeve Gastrectomy

> **NCT05522998** · PHASE4 · COMPLETED · sponsor: **The Third People's Hospital of Chengdu** · enrollment: 212 (actual)

## Conditions studied

- Bariatric Surgery

## Interventions

- **DRUG:** Ciprofol
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05522998
- **Lead sponsor:** The Third People's Hospital of Chengdu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05522998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05522998, "Efficacy and Safety of Ciprofol in Laparoscopic Sleeve Gastrectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05522998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*